Baxter Total Assets 2006-2020 | BAX

Baxter total assets from 2006 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Baxter total assets for the quarter ending June 30, 2020 were $19.465B, a 10.95% increase year-over-year.
  • Baxter total assets for 2019 were $18.193B, a 15.73% increase from 2018.
  • Baxter total assets for 2018 were $15.72B, a 8.13% decline from 2017.
  • Baxter total assets for 2017 were $17.111B, a 10.07% increase from 2016.
Baxter Annual Total Assets
(Millions of US $)
2019 $18,193
2018 $15,720
2017 $17,111
2016 $15,546
2015 $20,962
2014 $26,138
2013 $25,224
2012 $20,390
2011 $19,073
2010 $17,489
2009 $17,354
2008 $15,405
2007 $15,294
2006 $14,686
2005 $12,727
Baxter Quarterly Total Assets
(Millions of US $)
2020-06-30 $19,465
2020-03-31 $19,075
2019-12-31 $18,193
2019-09-30 $17,299
2019-06-30 $17,544
2019-03-31 $16,350
2018-12-31 $15,720
2018-09-30 $16,847
2018-06-30 $16,578
2018-03-31 $16,890
2017-12-31 $17,111
2017-09-30 $17,541
2017-06-30 $16,963
2017-03-31 $15,659
2016-12-31 $15,546
2016-09-30 $15,795
2016-06-30 $15,982
2016-03-31 $17,350
2015-12-31 $20,962
2015-09-30 $20,172
2015-06-30 $30,015
2015-03-31 $24,861
2014-12-31 $26,138
2014-09-30 $25,563
2014-06-30 $25,629
2014-03-31 $25,261
2013-12-31 $25,224
2013-09-30 $25,250
2013-06-30 $23,751
2013-03-31 $20,318
2012-12-31 $20,390
2012-09-30 $19,825
2012-06-30 $18,446
2012-03-31 $18,784
2011-12-31 $19,073
2011-09-30 $17,843
2011-06-30 $17,741
2011-03-31 $17,413
2010-12-31 $17,489
2010-09-30 $17,563
2010-06-30 $16,487
2010-03-31 $17,166
2009-12-31 $17,354
2009-09-30 $16,954
2009-06-30 $15,743
2009-03-31 $14,953
2008-12-31 $15,405
2008-09-30 $15,209
2008-06-30 $15,470
2008-03-31 $14,972
2007-12-31 $15,294
2007-09-30 $14,147
2007-06-30 $14,659
2007-03-31 $14,483
2006-12-31 $14,686
2006-09-30 $13,931
2006-06-30 $13,007
2006-03-31 $12,780
2005-12-31 $12,727
2005-09-30 $13,783
2005-06-30 $13,626
2005-03-31 $13,808
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $40.868B $11.362B
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $179.231B 33.63
Medtronic (MDT) Ireland $134.197B 21.80
Stryker (SYK) United States $71.795B 27.84
Boston Scientific (BSX) United States $55.753B 32.21
Lonza Group Ag (LZAGY) Switzerland $46.856B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.859B 23.95
Terumo (TRUMY) Japan $28.725B 36.72
EssilorLuxottica Societe Anonyme (ESLOY) France $28.171B 0.00
ResMed (RMD) United States $25.062B 36.40
Sunny Optical Technology (SNPTF) China $20.566B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $18.308B 0.00
Bio-Rad Laboratories (BIO) United States $15.555B 70.35
Insulet (PODD) United States $13.735B 604.81
Shandong Weigao Medical Polymer (SHWGF) China $12.315B 0.00
Quidel (QDEL) United States $11.442B 60.61
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
GN STORE NORD (GNNDY) Denmark $8.157B 41.58
William Demant Holdings (WILYY) Denmark $7.457B 0.00
Perrigo (PRGO) Ireland $6.885B 11.81
Hill-Rom Holdings (HRC) United States $6.336B 15.72
Canopy Growth (CGC) Canada $6.168B 0.00
Neogen (NEOG) United States $4.337B 72.47
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.204B 0.00
Haemonetics (HAE) United States $4.045B 26.95
Envista Holdings (NVST) United States $3.725B 25.40
ICU Medical (ICUI) United States $3.702B 27.01
Abcam (ABCZY) $3.462B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.396B 0.00
Agios Pharmaceuticals (AGIO) United States $2.988B 0.00
NuVasive (NUVA) United States $2.753B 38.36
National Vision Holdings (EYE) United States $2.678B 416.25
TG Therapeutics (TGTX) United States $2.314B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.945B 0.00
AtriCure (ATRC) United States $1.911B 0.00
MacroGenics (MGNX) United States $1.484B 0.00
NanoString Technologies (NSTG) United States $1.330B 0.00
Aphria (APHA) Canada $1.287B 0.00
Aurora Cannabis (ACB) Canada $1.186B 0.00
Cerus (CERS) United States $1.173B 0.00
Cardiovascular Systems (CSII) United States $1.097B 0.00
InMode (INMD) Israel $1.016B 25.62
OraSure Technologies (OSUR) United States $1.005B 0.00
Quanterix (QTRX) United States $0.942B 0.00
PetIQ (PETQ) United States $0.895B 25.85
Lantheus Holdings (LNTH) United States $0.888B 12.31
Meridian Bioscience (VIVO) United States $0.828B 19.13
Phibro Animal Health (PAHC) United States $0.825B 16.45
Owens & Minor (OMI) United States $0.813B 18.21
Vapotherm (VAPO) United States $0.781B 0.00
Omeros (OMER) United States $0.770B 0.00
BioLife Solutions (BLFS) United States $0.671B 350.33
Surmodics (SRDX) United States $0.650B 71.25
Eagle Pharmaceuticals (EGRX) United States $0.643B 46.08
VAREX IMAGING (VREX) United States $0.640B 15.90
LeMaitre Vascular (LMAT) United States $0.600B 36.62
Zynex (ZYXI) United States $0.591B 51.64
Cytosorbents (CTSO) United States $0.412B 0.00
Viemed Healthcare (VMD) United States $0.393B 14.04
Neptune Wellness Solutions (NEPT) Canada $0.325B 0.00
HEXO (HEXO) $0.319B 0.00
Utah Medical Products (UTMD) United States $0.294B 25.22
Organigram Holdings (OGI) Canada $0.223B 0.00
Chimerix (CMRX) United States $0.211B 0.00
Female Health (VERU) United States $0.208B 0.00
Exagen (XGN) United States $0.179B 0.00
Bovie Medical (APYX) United States $0.171B 0.00
Surface Oncology (SURF) United States $0.170B 0.00
Fonar (FONR) United States $0.166B 14.75
Wound Management Technologies (SMTI) United States $0.153B 0.00
Liberty Health Sciences (LHSIF) Canada $0.128B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.123B 0.00
Evolus (EOLS) United States $0.118B 0.00
Rockwell Medical (RMTI) United States $0.115B 0.00
Chembio Diagnostics (CEMI) United States $0.111B 0.00
Capricor Therapeutics (CAPR) United States $0.093B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
MTech Acquisition (KERN) United States $0.087B 0.00
Nephros (NEPH) United States $0.071B 0.00
United-Guardian (UG) United States $0.069B 15.58
Brainsway (BWAY) Israel $0.067B 0.00
Trinity Biotech (TRIB) Ireland $0.063B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Akers Biosciences Inc (AKER) United States $0.037B 0.00
GUARDION HEALTH (GHSI) United States $0.035B 0.00
FSD PHARMA INC (HUGE) Canada $0.027B 0.00
NF Energy Saving (BIMI) China $0.023B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Senestech (SNES) United States $0.007B 0.00